Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-6,525
Closed -$621K – 719
2017
Q3
$621K Buy
6,525
+3,000
+85% +$289K 0.09% 401
2017
Q2
$336K Buy
+3,525
New +$301K 0.04% 631
2017
Q1
– Sell
-15,504
Closed -$1.04M – 889
2016
Q4
$1.04M Buy
15,504
+8,300
+115% +$512K 0.09% 410
2016
Q3
$432K Sell
7,204
-7,203
-50% -$401K 0.04% 605
2016
Q2
$722K Buy
14,407
+4,500
+45% +$215K 0.1% 372
2016
Q1
$446K Buy
+9,907
New +$353K 0.06% 542
2015
Q3
– Sell
-16,742
Closed -$747K – 747
2015
Q2
$747K Buy
+16,742
New +$642K 0.12% 316

Other funds holding INGN

Menta Capital's INGN Position: Q4 2017 in Review

Menta Capital sold out of Inogen (INGN) in Q4 2017, closing a stake of 6,525 shares — an estimated $621K sold.

Menta Capital first reported a position in INGN in Q2 2015 and held it in 7 quarters. The position peaked at $1.04M in Q4 2016. 220 funds tracked by Wall St. Rank hold INGN as of Q4 2017.

  • Menta Capital reported no remaining Inogen position as of Q4 2017 after selling out during the quarter.
  • Menta Capital sold 6,525 Inogen shares in Q4 2017, an estimated $621K.
  • Menta Capital first reported a position in Inogen in Q2 2015 and held it in 7 quarters.
  • Menta Capital's Inogen position peaked at $1.04M in Q4 2016.
  • 220 funds tracked by Wall St. Rank held Inogen as of Q4 2017.

Based on Menta Capital's 13F filing for Q4 2017, filed 14 Feb 2018.